Bladder, Breast, and Colorectal Cancer- Treatment Summary Table
Only one measure per topic is displayed in the summary table. A complete set of measures, where they exist, can be found by following the More Information link in the table below.
![]() |
green - headed in the right direction |
![]() |
red - headed in the wrong direction |
![]() |
black - stable or non-significant change (NSC) |
![]() |
purple - indeterminate |
![]() |
blue - Healthy People 2020 target |
Measure Name | Bladder Cancer Treatment | Breast Cancer Treatment | Colorectal Cancer Treatment |
---|---|---|---|
Year Range | 1995-2009 | 1987-2015 | 1987-2015 |
Measure |
Percentage of individuals receiving intravesical therapy in non-muscle invasive bladder cancer. |
Percentage of women aged 20 and older, diagnosed with early stage breast cancer (local or regional stage), receiving breast-conserving surgery and radiation treatment. Percentage of women aged 20 and older, diagnosed with node-positive, stage I–IIIA breast cancer, receiving multi-agent chemotherapy. |
Percent of individuals, aged 20 years and older, diagnosed with stage III colon cancer who received chemotherapy or diagnosed with stage II or stage III rectal cancer who received chemotherapy with or without radiation therapy. |
Recent Summary Trend | Non-Significant Change | Stable | Rising |
Recent Summary Trend Year Range | 2003-2009 | 2010-2015 | 2010-2015 |
Desired Direction | Rising | Rising | Rising |
Summary Graph |
![]() |
![]() |
![]() |
Trends and Most Recent Estimates | In 2009, 29.7% of patients with non-muscle invasive disease received intravesical therapy. | In 2015, 64.2% of women diagnosed with node positive breast cancer, received multi-agent chemotherapy. | In 2015, 70.3% of stage III colon and stage II and III rectal patients received adjuvant chemotherapy. |
Healthy People 2020 Target | There are no Healthy People 2020 targets for cancer treatment, including bladder cancer treatment. | There are no Healthy People 2020 targets for cancer treatment, including breast cancer treatment. | There are no Healthy People 2020 targets for cancer treatment, including colorectal cancer treatment. |
More Information | Bladder Cancer Treatment | Breast Cancer Treatment | Colorectal Cancer Treatment |
Last Updated | March 2020 | March 2020 | March 2020 |
Measure Name | Colorectal Cancer Treatment |
---|---|
Year Range | 1987-2015 |
Measure |
Percent of individuals, aged 20 years and older, diagnosed with stage III colon cancer who received chemotherapy or diagnosed with stage II or stage III rectal cancer who received chemotherapy with or without radiation therapy. |
Recent Summary Trend | Rising |
Recent Summary Trend Year Range | 2010-2015 |
Desired Direction | Rising |
Summary Graph |
![]() |
Trends and Most Recent Estimates | In 2015, 70.3% of stage III colon and stage II and III rectal patients received adjuvant chemotherapy. |
Healthy People 2020 Target | There are no Healthy People 2020 targets for cancer treatment, including colorectal cancer treatment. |
More Information | Colorectal Cancer Treatment |
Measure Name | Bladder Cancer Treatment |
---|---|
Year Range | 1995-2009 |
Measure |
Percentage of individuals receiving intravesical therapy in non-muscle invasive bladder cancer. |
Recent Summary Trend | Non-Significant Change |
Recent Summary Trend Year Range | 2003-2009 |
Desired Direction | Rising |
Summary Graph |
![]() |
Trends and Most Recent Estimates | In 2009, 29.7% of patients with non-muscle invasive disease received intravesical therapy. |
Healthy People 2020 Target | There are no Healthy People 2020 targets for cancer treatment, including bladder cancer treatment. |
More Information | Bladder Cancer Treatment |
Measure Name | Breast Cancer Treatment |
---|---|
Year Range | 1987-2015 |
Measure |
Percentage of women aged 20 and older, diagnosed with early stage breast cancer (local or regional stage), receiving breast-conserving surgery and radiation treatment. Percentage of women aged 20 and older, diagnosed with node-positive, stage I–IIIA breast cancer, receiving multi-agent chemotherapy. |
Recent Summary Trend | Stable |
Recent Summary Trend Year Range | 2010-2015 |
Desired Direction | Rising |
Summary Graph |
![]() |
Trends and Most Recent Estimates | In 2015, 64.2% of women diagnosed with node positive breast cancer, received multi-agent chemotherapy. |
Healthy People 2020 Target | There are no Healthy People 2020 targets for cancer treatment, including breast cancer treatment. |
More Information | Breast Cancer Treatment |